Complex karyotype newly defined: The strongest prognostic factor in advanced childhood myelodysplastic syndrome

Gudrun Göhring, Kyra Michalova, H. Berna Beverloo, David Betts, Jochen Harbott, Oskar A. Haas, Gitte Kerndrup, Laura Sainati, Eva Bergstraesser, Henrik Hasle, Jan Starý, Monika Trebo, Marry M. Van Den Heuvel-Eibrink, Marco Zecca, Elisabeth R. Van Wering, Alexandra Fischer, Peter Noellke, Brigitte Strahm, Franco Locatelli, Charlotte M. NiemeyerBrigitte Schlegelberger

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

To identify cytogenetic risk factors predicting outcome in children with advanced myelodysplastic syndrome, overall survival of 192 children prospectively enrolled in European Working Group of Myelodysplastic Syndrome in Childhood studies was evaluated with regard to karyotypic complexity. Structurally complex constitutes a new definition of complex karyotype characterized by more than or equal to 3 chromosomal aberrations, including at least one structural aberration. Five-year overall survival in patients with more than or equal to 3 clonal aberrations, which were not structurally complex, did not differ from that observed in patients with normal karyotype. Cox regression analysis revealed the presence of a monosomal and structurally complex karyotype to be strongly associated with poor prognosis (hazard ratio = 4.6, P <.01). Notably, a structurally complex karyotype without a monosomy was associated with a very short 2-year overall survival probability of only 14% (hazard ratio = 14.5; P <.01). The presence of a structurally complex karyotype was the strongest independent prognostic marker predicting poor outcome in children with advanced myelodysplastic syndrome.

Original languageEnglish
Pages (from-to)3766-3769
Number of pages4
JournalBlood
Volume116
Issue number19
DOIs
Publication statusPublished - Nov 11 2010

Fingerprint

Myelodysplastic Syndromes
Aberrations
Karyotype
Hazards
Survival
Regression analysis
Monosomy
Cytogenetics
Chromosome Aberrations
Regression Analysis

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Göhring, G., Michalova, K., Beverloo, H. B., Betts, D., Harbott, J., Haas, O. A., ... Schlegelberger, B. (2010). Complex karyotype newly defined: The strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood, 116(19), 3766-3769. https://doi.org/10.1182/blood-2010-04-280313

Complex karyotype newly defined : The strongest prognostic factor in advanced childhood myelodysplastic syndrome. / Göhring, Gudrun; Michalova, Kyra; Beverloo, H. Berna; Betts, David; Harbott, Jochen; Haas, Oskar A.; Kerndrup, Gitte; Sainati, Laura; Bergstraesser, Eva; Hasle, Henrik; Starý, Jan; Trebo, Monika; Van Den Heuvel-Eibrink, Marry M.; Zecca, Marco; Van Wering, Elisabeth R.; Fischer, Alexandra; Noellke, Peter; Strahm, Brigitte; Locatelli, Franco; Niemeyer, Charlotte M.; Schlegelberger, Brigitte.

In: Blood, Vol. 116, No. 19, 11.11.2010, p. 3766-3769.

Research output: Contribution to journalArticle

Göhring, G, Michalova, K, Beverloo, HB, Betts, D, Harbott, J, Haas, OA, Kerndrup, G, Sainati, L, Bergstraesser, E, Hasle, H, Starý, J, Trebo, M, Van Den Heuvel-Eibrink, MM, Zecca, M, Van Wering, ER, Fischer, A, Noellke, P, Strahm, B, Locatelli, F, Niemeyer, CM & Schlegelberger, B 2010, 'Complex karyotype newly defined: The strongest prognostic factor in advanced childhood myelodysplastic syndrome', Blood, vol. 116, no. 19, pp. 3766-3769. https://doi.org/10.1182/blood-2010-04-280313
Göhring G, Michalova K, Beverloo HB, Betts D, Harbott J, Haas OA et al. Complex karyotype newly defined: The strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood. 2010 Nov 11;116(19):3766-3769. https://doi.org/10.1182/blood-2010-04-280313
Göhring, Gudrun ; Michalova, Kyra ; Beverloo, H. Berna ; Betts, David ; Harbott, Jochen ; Haas, Oskar A. ; Kerndrup, Gitte ; Sainati, Laura ; Bergstraesser, Eva ; Hasle, Henrik ; Starý, Jan ; Trebo, Monika ; Van Den Heuvel-Eibrink, Marry M. ; Zecca, Marco ; Van Wering, Elisabeth R. ; Fischer, Alexandra ; Noellke, Peter ; Strahm, Brigitte ; Locatelli, Franco ; Niemeyer, Charlotte M. ; Schlegelberger, Brigitte. / Complex karyotype newly defined : The strongest prognostic factor in advanced childhood myelodysplastic syndrome. In: Blood. 2010 ; Vol. 116, No. 19. pp. 3766-3769.
@article{dfc1cee84ce249cc9b3e4eee34e9289d,
title = "Complex karyotype newly defined: The strongest prognostic factor in advanced childhood myelodysplastic syndrome",
abstract = "To identify cytogenetic risk factors predicting outcome in children with advanced myelodysplastic syndrome, overall survival of 192 children prospectively enrolled in European Working Group of Myelodysplastic Syndrome in Childhood studies was evaluated with regard to karyotypic complexity. Structurally complex constitutes a new definition of complex karyotype characterized by more than or equal to 3 chromosomal aberrations, including at least one structural aberration. Five-year overall survival in patients with more than or equal to 3 clonal aberrations, which were not structurally complex, did not differ from that observed in patients with normal karyotype. Cox regression analysis revealed the presence of a monosomal and structurally complex karyotype to be strongly associated with poor prognosis (hazard ratio = 4.6, P <.01). Notably, a structurally complex karyotype without a monosomy was associated with a very short 2-year overall survival probability of only 14{\%} (hazard ratio = 14.5; P <.01). The presence of a structurally complex karyotype was the strongest independent prognostic marker predicting poor outcome in children with advanced myelodysplastic syndrome.",
author = "Gudrun G{\"o}hring and Kyra Michalova and Beverloo, {H. Berna} and David Betts and Jochen Harbott and Haas, {Oskar A.} and Gitte Kerndrup and Laura Sainati and Eva Bergstraesser and Henrik Hasle and Jan Star{\'y} and Monika Trebo and {Van Den Heuvel-Eibrink}, {Marry M.} and Marco Zecca and {Van Wering}, {Elisabeth R.} and Alexandra Fischer and Peter Noellke and Brigitte Strahm and Franco Locatelli and Niemeyer, {Charlotte M.} and Brigitte Schlegelberger",
year = "2010",
month = "11",
day = "11",
doi = "10.1182/blood-2010-04-280313",
language = "English",
volume = "116",
pages = "3766--3769",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "19",

}

TY - JOUR

T1 - Complex karyotype newly defined

T2 - The strongest prognostic factor in advanced childhood myelodysplastic syndrome

AU - Göhring, Gudrun

AU - Michalova, Kyra

AU - Beverloo, H. Berna

AU - Betts, David

AU - Harbott, Jochen

AU - Haas, Oskar A.

AU - Kerndrup, Gitte

AU - Sainati, Laura

AU - Bergstraesser, Eva

AU - Hasle, Henrik

AU - Starý, Jan

AU - Trebo, Monika

AU - Van Den Heuvel-Eibrink, Marry M.

AU - Zecca, Marco

AU - Van Wering, Elisabeth R.

AU - Fischer, Alexandra

AU - Noellke, Peter

AU - Strahm, Brigitte

AU - Locatelli, Franco

AU - Niemeyer, Charlotte M.

AU - Schlegelberger, Brigitte

PY - 2010/11/11

Y1 - 2010/11/11

N2 - To identify cytogenetic risk factors predicting outcome in children with advanced myelodysplastic syndrome, overall survival of 192 children prospectively enrolled in European Working Group of Myelodysplastic Syndrome in Childhood studies was evaluated with regard to karyotypic complexity. Structurally complex constitutes a new definition of complex karyotype characterized by more than or equal to 3 chromosomal aberrations, including at least one structural aberration. Five-year overall survival in patients with more than or equal to 3 clonal aberrations, which were not structurally complex, did not differ from that observed in patients with normal karyotype. Cox regression analysis revealed the presence of a monosomal and structurally complex karyotype to be strongly associated with poor prognosis (hazard ratio = 4.6, P <.01). Notably, a structurally complex karyotype without a monosomy was associated with a very short 2-year overall survival probability of only 14% (hazard ratio = 14.5; P <.01). The presence of a structurally complex karyotype was the strongest independent prognostic marker predicting poor outcome in children with advanced myelodysplastic syndrome.

AB - To identify cytogenetic risk factors predicting outcome in children with advanced myelodysplastic syndrome, overall survival of 192 children prospectively enrolled in European Working Group of Myelodysplastic Syndrome in Childhood studies was evaluated with regard to karyotypic complexity. Structurally complex constitutes a new definition of complex karyotype characterized by more than or equal to 3 chromosomal aberrations, including at least one structural aberration. Five-year overall survival in patients with more than or equal to 3 clonal aberrations, which were not structurally complex, did not differ from that observed in patients with normal karyotype. Cox regression analysis revealed the presence of a monosomal and structurally complex karyotype to be strongly associated with poor prognosis (hazard ratio = 4.6, P <.01). Notably, a structurally complex karyotype without a monosomy was associated with a very short 2-year overall survival probability of only 14% (hazard ratio = 14.5; P <.01). The presence of a structurally complex karyotype was the strongest independent prognostic marker predicting poor outcome in children with advanced myelodysplastic syndrome.

UR - http://www.scopus.com/inward/record.url?scp=78149432321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149432321&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-04-280313

DO - 10.1182/blood-2010-04-280313

M3 - Article

C2 - 20802024

AN - SCOPUS:78149432321

VL - 116

SP - 3766

EP - 3769

JO - Blood

JF - Blood

SN - 0006-4971

IS - 19

ER -